Roche Financials

Market Capitalization CHF206.01 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	24.92
Forward PE	12.53
Price to Sales TTM	CHF3.30
Price to Book MRQ	CHF6.43
Enterprise to Revenue	3.67
Enterprise to EBITDA	10.08

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-12-31
Profit Margin	13.26%
Operating Margin	27.72%
Return on Assets TTM	12.75%
Return on Equity TTM	26.47%

Income Statement

Revenue TTM	CHF62,394,998,784
Revenue per Share TTM	CHF78.29
Quarterly Revenue Growth	6.10%
Gross Profit TTM	CHF46,663,999,488
EBITDA	CHF16,726,000,000
Net Income to Common TTM	CHF8,277,000,192
Diluted EPS TTM	CHF10.30
Quarterly Earnings Growth YoY	-53.70%

Balance Sheet

Total Cash MRQ	CHF17,333,000,192
Total Cash per Share MRQ	CHF21.79
Total Debt MRQ	CHF
Total Debt to Equity MRQ	100.60
Current Ratio MRQ	1.48
Book Value per Share MRQ	CHF39.94

Cash Flow

Operating Cash Flow TTM	CHF20,093,999,104
Levered Free Cash Flow TTM	CHF13,666,624,512

ROG Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	795,400,695
Float Shares	725,604,284
Avg 10 Volume	775,071
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.00%
% Held by Institutions	39.66%

Stock Price Summary

Beta	0.17
Fifty Two Week Low	CHF231.90
Fifty Two Week High	CHF313.80
Fifty Two Week Change	6.39%
Day 50 MA	CHF263.45
Day 200 MA	CHF270.30

Dividends and Splits

Forward Annual Dividend Rate	CHF38.80
Forward Annual Dividend Yield	14.93%
Trailing Annual Dividend Rate	CHF9.70
Trailing Annual Dividend Yield	3.73%
Payout Ratio	93.11%
Dividend Date	2025-03-31
Ex Dividend Date	2025-03-27
Last Split Factor
Last Split Date	2001-05-04